Ferrari N.V. (RACE.MI)
| Previous Close | 391.60 |
| Open | 386.90 |
| Bid | 386.40 x 0 |
| Ask | 386.80 x 0 |
| Day's Range | 383.90 - 392.50 |
| 52 Week Range | 248.00 - 410.10 |
| Volume | |
| Avg. Volume | 321,126 |
| Market Cap | 69.732B |
| Beta (5Y Monthly) | 0.97 |
| PE Ratio (TTM) | 56.20 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.44 (0.62%) |
| Ex-Dividend Date | Apr 22, 2024 |
| 1y Target Est | N/A |
- Reuters
New Ferrari 'e-facility' will give ample capacity for electrification, CEO says
Ferrari's new assembly facility, its so called 'e-building', in its Maranello hometown in northern Italy, will give the luxury sportscar maker capacity to expand its offer of electrified cars in coming years, its CEO said on Wednesday. The e-building will be inaugurated on June 21, Ferrari Chief Executive Benedetto Vigna told investors during the company's annual general meeting (AGM). "This state of the art plant will assure us of flexibility and technical capacity in excess of our needs for years to come," he said.
- Zacks
Auto Roundup: KMX's Weak Quarterly Results, TSLA's FSD Price Cut & More
While CarMax's (KMX) fiscal fourth-quarter 2024 earnings and sales miss estimates, Tesla (TSLA) slashes the monthly subscription price of FSD software to half.
- Reuters
UPDATE 1-Agnellis' Exor targets growth in healthcare sector
Exor, the investment arm of the Agnelli family, has a growing interest in the healthcare industry, where it has already invested almost 4 billion euros ($4.3 billion), CEO John Elkann said on Thursday. "The increased cost of healthcare services combined with a shortage of medical staff is driving demand for innovative new approaches to tackle global health problems," he said in his annual letter to Exor shareholders. Exor views healthcare as a "long-term, structural growth sector," added Elkann, the scion of the Agnelli family and chair of automakers Stellantis and Ferrari.
